Other risk factors for the development of MPNST include the presence of an inherited gross deletion of the entire NF1 gene region in 17q11.2 [7], previous radiation therapy [7], the presence of neurofibromatous neuropathy [8], as well as a family history of MPNSTs [9]. Here, NF1 is linked to malignant peripheral nerve sheath tumor.